-
Mashup Score: 0Modified FOLFIRINOX Versus CISGEM Chemotherapy for Patients With Advanced Biliary Tract Cancer (PRODIGE 38 AMEBICA): A Randomized Phase II Study - 3 year(s) ago
PURPOSE Whether triplet chemotherapy is superior to doublet chemotherapy in advanced biliary tract cancer (BTC) is unknown. METHODS In this open-label, randomized phase II-III study, patients with locally advanced or metastatic BTC and an Eastern Cooperative Oncology Group performance status of 0 or 1 were randomly assigned (1:1) to receive oxaliplatin, irinotecan, and infusional fluorouracil…
Source: Journal of Clinical OncologyCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 4Modified FOLFIRINOX Versus CISGEM Chemotherapy for Patients With Advanced Biliary Tract Cancer (PRODIGE 38 AMEBICA): A Randomized Phase II Study - 3 year(s) ago
PURPOSE Whether triplet chemotherapy is superior to doublet chemotherapy in advanced biliary tract cancer (BTC) is unknown. METHODS In this open-label, randomized phase II-III study, patients with locally advanced or metastatic BTC and an Eastern Cooperative Oncology Group performance status of 0 or 1 were randomly assigned (1:1) to receive oxaliplatin, irinotecan, and infusional fluorouracil…
Source: Journal of Clinical OncologyCategories: Latest Headlines, Oncologists1Tweet-
A disappointed hope, but proud to have contributed to the (difficult) therapeutic research in advanced #biliary #cancer. @CCA_Alliance @curecc https://t.co/APHZRAeYMK
-
-
Mashup Score: 0
Adding liposomal irinotecan to fluorouracil and leucovorin significantly improved BICR-assessed progression-free survival in patients with advanced biliary tract cancer. Liposomal irinotecan plus fluorouracil and leucovorin could be considered a standard-of-care second-line therapy for advanced biliary tract cancer.
Source: The Lancet OncologyCategories: Latest Headlines, Oncologists1Tweet-
Liposomal irinotecan➕5FU 🆚 5FU in #patients è met #biliary #cancer after PD on GEM/CIS. @TheLancetOncol ➡️PFS (7·1 🆚 1·4 mos, HR 0·56, p=0·0019). V imp trial but would you use FOLFIRI instead? Or FOLFOX? @OncoAlert https://t.co/Ox5S1nEFFL
-
-
Mashup Score: 1Organoid Success Reveals Polarity Defect and Potential Target for Future Treatment of Biliary Atresia | Research Horizons - 3 year(s) ago
Experts at Cincinnati Children’s Develop Organoid to Mimic Biliary Atresia, Discover Potential Target for Treatment
Source: Research HorizonsCategories: Healthcare Professionals, Latest HeadlinesTweet-
Check out this post from Cincinnati Children's - Organoid Success Reveals Polarity Defect and Potential Target for Future Treatment of Biliary Atresia #some4surgery #some4pedsurg #atresia #biliary https://t.co/YLy5FOiMTO
-
-
Mashup Score: 0AGA's Gastro Cards App - 3 year(s) ago
Perfect for clinicians and fellows-in-training on-the-go, AGA’s digital flashcards, Gastro Cards, provides instant answers to vexing challenges from endoscopies to IBD and more. With hundreds of short-form true-false and open-ended questions that are updated regularly, the app is an ideal complement to other AGA learning tools such as DDSEP® 9, Board Review Course and the GI Self-Assessment…
Source: agau.gastro.orgCategories: Gastroenterology, Latest HeadlinesTweet-
Think you are up to speed on #biliary track problems? Test yourself with this sample question from AGA’s flashcard quiz app, Gastro Cards. There are hundreds more questions just like this one to test your knowledge and improve your skills. https://t.co/bw9tD3Va8D https://t.co/nwC1YbdtL5
-
-
Mashup Score: 0Cholangiocyte Organoids as a Cell Source for Biliary Repair - 3 year(s) ago
Preoccupied with the astounding regenerative capabilities and metabolic importance of hepatocytes in the liver, the role of the resident “plumbers” of the liver, the cholangiocytes, can be overlooked…
Source: Wiley Online LibraryCategories: Latest Headlines, TransplantationTweet-
Organoids are three dimensional cellular systems developed from stem cells and their progeny via process of cell sorting, differentiation and self-organization. Read our news and views: #Cholangiocyte #Organoids as a Cell Source for #Biliary #Repair https://t.co/z9UbTIdK81
-
-
Mashup Score: 0
Biliary tract complications (BTCs) still burden liver transplantation (LT). The wide reporting variability highlights the absence of systematic screening. From 2000 to 2009, simultaneous liver biopsy…
Source: Wiley Online LibraryCategories: Latest Headlines, TransplantationTweet-
Abnormal #biliary #tract at imaging in the presence of #canalicular proliferation at pathology is associated with reduced #liver graft survival, thus representing a useful tool to intensify follow‐up and help timely #retransplant @ElianoRiani @JanLerut https://t.co/qCFxfKNSXA https://t.co/JS4V0UophU
-
-
Mashup Score: 0Pardon Our Interruption - 4 year(s) ago
As you were browsing www.gastroendonews.com something about your browser made us think you were a bot. There are a few reasons this might happen: You’re a power user moving through this website with super-human speed. You’ve disabled JavaScript in your web browser. A third-party browser plugin, such as…
Source: www.gastroendonews.comCategories: Gastroenterology, Latest HeadlinesTweet-
The grip of #biliary atresia may be lessening on #pediatric populations around the world, thanks to recent #scientific advances. https://t.co/ORiCzuyRfE @CUMedicalSchool @dbmogul @HopkinsMedicine #liverdisease #pediatrics
-
-
Mashup Score: 0Drs. Kevin Kelly and Harish Lavu - Strides Toward the Cure - 4 year(s) ago
This is “Drs. Kevin Kelly and Harish Lavu – Strides Toward the Cure” by Matthew Huesser on Vimeo, the home for high quality videos and the people who love…
Source: VimeoCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
On the "Strides Toward the Cure" podcast, host Dr. @wkkelly2708 interviewed @JEFFsurgery's Dr. Harish Lavu about the ongoing WASH (Water or Saline at High Volumes) Trial for patients undergoing surgical removal of a #pancreatic or #biliary tumor: https://t.co/e6IKsWB9Fs #pancsm
-
@ASCO_pubs #JCO ➡️ PRODIGE 38 AMEBICA #clinicaltrial mPFS 6.2 in FFX 🆚7.4 months in the CIS/GEM arm. mOS 11.7 in FFX 🆚13.8 months in CIS/GEM. GEM/CIS remains to be the SOC!! Very interesting results.#biliary #cancers @OncoAlert https://t.co/u992tkdaVl